Platte River Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$3.91M Sell
46,681
-17,191
-27% -$1.45M 3.6% 3
2015
Q2
$5.33M Sell
63,872
-4,038
-6% -$308K 2.68% 5
2015
Q1
$4.93M Sell
67,910
-12,000
-15% -$854K 2.22% 6
2014
Q4
$5.51M Sell
79,910
-30,440
-28% -$2.05M 2.05% 7
2014
Q3
$7.16M Sell
110,350
-51,730
-32% -$3.28M 1.85% 8
2014
Q2
$10.1M Sell
162,080
-5,350
-3% -$319K 1.53% 10
2014
Q1
$9.86M Buy
167,430
+89,770
+116% +$5.01M 1.34% 12
2013
Q4
$3.96M Sell
77,660
-4,700
-6% -$235K 0.51% 70
2013
Q3
$4.14M Sell
82,360
-5,790
-7% -$303K 0.51% 73
2013
Q2
$4.33M Buy
+88,150
New +$4.8M 0.5% 76

Other funds holding LLY

Platte River Capital's LLY Position: Q3 2015 in Review

Platte River Capital reduced its Eli Lilly (LLY) stake by 27% in Q3 2015, selling an estimated $1.45M and leaving 46,681 shares worth $3.91M. The position accounts for 3.6% of the portfolio, ranked #3.

Platte River Capital first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. The position peaked at $10.1M in Q2 2014. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • Platte River Capital held 46,681 shares of Eli Lilly worth $3.91M as of Q3 2015.
  • Platte River Capital sold 17,191 Eli Lilly shares in Q3 2015, an estimated $1.45M.
  • Eli Lilly made up 3.6% of Platte River Capital's portfolio in Q3 2015, its #3 holding.
  • Platte River Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
  • Platte River Capital's Eli Lilly position peaked at $10.1M in Q2 2014.
  • 1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.